Controllable gene delivery via masked adeno-associated viral vectors.
Systemic administration of protease-activated masked AAVs enables tissue-specific gene delivery to the liver, while administration of near-infrared-activated masked AAVs provides localized transduction in irradiated regions such as muscles and brain.